Compare KW & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KW | CERT |
|---|---|---|
| Founded | 1977 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1546 |
| Industry | Real Estate | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 1992 | 2020 |
| Metric | KW | CERT |
|---|---|---|
| Price | $9.95 | $8.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $11.00 | ★ $13.88 |
| AVG Volume (30 Days) | 1.0M | ★ 2.0M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 4.87% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $550,500,000.00 | $415,551,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | $158.40 | $6.77 |
| P/E Ratio | ★ N/A | $126.84 |
| Revenue Growth | ★ 13.93 | 11.47 |
| 52 Week Low | $5.98 | $8.03 |
| 52 Week High | $11.36 | $15.69 |
| Indicator | KW | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 64.72 | 38.18 |
| Support Level | $9.68 | $8.95 |
| Resistance Level | $9.98 | $9.42 |
| Average True Range (ATR) | 0.13 | 0.39 |
| MACD | -0.04 | 0.06 |
| Stochastic Oscillator | 79.10 | 13.72 |
Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.